BOSTON--(BUSINESS WIRE)--PHT Corporation announced that Chelsea Therapeutics is using PHT’s LogPad® System and SitePad® Tablet for its ongoing clinical study in Parkinson’s disease patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback